Enhanced antiproliferative activity of carboplatin-loaded chitosan-alginate nanoparticles in a retinoblastoma cell line

Acta Biomaterialia

Volumn 6, Issue 8, 2010, Pages 3120-3131

  Parveen, Suphiya ^a   Mitra, Moutushy ^b   Krishnakumar, S ^b   Sahoo, Sanjeeb K ^a  

^a INSTITUTE OF LIFE SCIENCES   (India)

^b VISION RESEARCH FOUNDATION   (India)

Author keywords

Carboplatin; Chitosan; Nanoparticles; Ocular drug delivery; Retinoblastoma

Indexed keywords

CELL CULTURE; CHITOSAN; CONTROLLED DRUG DELIVERY; CYTOTOXICITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DOSAGE; DRUG PRODUCTS; ENCAPSULATION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; MOLECULAR BIOLOGY; SCANNING ELECTRON MICROSCOPY; TARGETED DRUG DELIVERY;

ANTIPROLIFERATIVE ACTIVITIES; CARBOPLATIN; CHITOSAN ALGINATES; DRUG ENCAPSULATION; IN-VITRO; OCULAR DRUG DELIVERY; RETINOBLASTOMA; RETINOBLASTOMA CELL LINES; SUSTAINED RELEASE; VITRO RELEASE;

NANOPARTICLES;

CARBOPLATIN; CHITOSAN; NANOPARTICLE; ALGINIC ACID; GLUCURONIC ACID; HEXURONIC ACID;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CLINICAL EVALUATION; CONFOCAL LASER MICROSCOPY; CYTOTOXICITY; DIFFERENTIAL SCANNING CALORIMETRY; DNA FRAGMENTATION; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MECHANISM; DRUG UPTAKE; ENDOCYTOSIS; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; RETINOBLASTOMA; SUSTAINED DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY; CELL DEATH; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; INTRACELLULAR SPACE; METABOLISM; PARTICLE SIZE; PATHOLOGY; TIME; TUMOR CELL LINE; ULTRASTRUCTURE;

ALGINATES; CALORIMETRY, DIFFERENTIAL SCANNING; CARBOPLATIN; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CHITOSAN; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; INTRACELLULAR SPACE; NANOPARTICLES; PARTICLE SIZE; RETINOBLASTOMA; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TIME FACTORS;

EID: 77956638462     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2010.02.010     Document Type: Article

References (57)

1. Rodriguez-Galindo C, Wilson MW, Chantada G, Fu L, Qaddoumi I, Antoneli C, Leal-Leal C, et al. Retinoblastoma: one world, one vision. Pediatrics 2008;122:e763.
2. Van Quill KR, Dioguardi PK, Tong CT, Gilbert JA, Aaberg Jr TM, Grossniklaus HE, et al. Ophthalmology 2005;112:1151.
3. Ellsworth RM. Retinoblastoma. Mod Probl Ophthalmol 1977;18:94.
4. Amendola BE, Markoe AM, Augsburger JJ, Karlsson UL, Giblin M, Shields JA, et al. Analysis of treatment results in 36 children with retinoblastoma treated by scleral plaque irradiation. Int J Radiat Oncol Biol Phys 1989;17:63.
5. Abramson DH, Frank CM. Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk. Ophthalmology 1998;105:573.
6. Chan HS, Canton MD, Gallie BL. Chemosensitivity and multidrug resistance to antineoplastic drugs in retinoblastoma cell lines. Anticancer Res 1989;9:469.
7. Parveen S, Sahoo SK. Polymeric nanoparticles for cancer therapy. J Drug Target 2008;16:108.
8. Sahoo SK, Parveen S, Panda JJ. The present and future of nanotechnology in human health care. Nanomedicine 2007;3:20.
9. Alonso MJ, Sanchez A. Biodegradable nanoparticles as new transmucosal drug carriers. In S. Svenson (ed.), Carrier-Based Drug Delivery. ACS Symposium Series Vol. 879, 2004, ch. 20.
10. de Campos AM, Sanchez A, Alonso MJ. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int J Pharm 2001;224:159.
11. Calvo P, Vila-Jato JL, Alonso MJ. Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int J Pharm 1997;53:41.
12. Genta I, Conti B, Perugini P, Pavanetto F, Spadaro A, Puglisi G. Bioadhesive microspheres for ophthalmic administration of acyclovir. J Pharm Pharmacol 1997;49:737.
13. Short BG. Safety evaluation of ocular drug delivery formulations: techniques and practical considerations. Toxicol Pathol 2008;36:49.
14. Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polymer Sci 1997;63:125.
15. Gallie BL, Bunding AS, Chan H. New chemotherapy and focal therapy for intraocular retinoblastoma. Ophthalmology 1995;102(Suppl.):109.
16. Shields CL, De Potter P, Himelstein BP, Shields JA, Meadows AT, Maris JM. Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol 1996;114:1330.
17. Mittal A, Chitkara D, Kumar N. HPLC method for the determination of carboplatin and paclitaxel with cremophorEL in an amphiphilic polymer matrix. J Chromatogr B Anal Technol Biomed Life Sci 2007;855:211.
18. Griesinger F, Metz M, Trumper L, Schulz T, Haase D. Secondary leukaemia after cure for locally advanced NSCLC: alkylating type secondary leukaemia after induction therapy with docetaxel and carboplatin for NSCLC IIIB. Lung Cancer 2004;44:261.
19. Motwani SK, Chopra S, Talegaonkar S, Kohli K, Ahmad FJ, Khar RK. Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation. Eur J Pharm Biopharm 2008;68:513.
20. Fizet J, Riviere C, Bridot JL, Charvet N, Louis C, Billotey C, et al. Multiluminescent hybrid gadolinium oxide nanoparticles as potential cell labeling. J Nanosci Nanotechnol 2009;9:5717.
21. Yang H, Li K, Liu Y, Liu Z, Miyoshi H. Poly (D, L-lactide-co-glycolide) nanoparticles encapsulated fluorescent isothiocyanate and paclitaxol: preparation, release kinetics and anticancer effect. J Nanosci Nanotechnol 2009;9:282.
22. Enriquez de Salamanca A, Diebold Y, Calonge M, Garcia-Vazquez C, Callejo S, Vila A, et al. Invest Ophthalmol Vis Sci 2006;47:1416.
23. Dodane V, Vilivalam D. Pharmaceutical applications of chitosan. Pharm Sci Technol Today 1998;1:246.
24. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55.
25. Al-Joudi FS, Alias IZ, Samsudin AR. The effects of chemotherapeutic drugs on viability, apoptosis, and survivin expression in MCF-7 cells. Acta Histochem Cytochem 2005;38:323.
26. Sahoo SK, Labhasetwar V. Enhanced antiproliferative activity of transferrinconjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol Pharm 2005;2:373.
27. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994;84:1415.
28. Ioannou YA, Chen FW. Quantitation of DNA fragmentation in apoptosis. Nucleic Acids Res 1996;24:992.
29. Mo Y, Barnett ME, Takemoto D, Davidson H, Kompella UB. Human serum albumin nanoparticles for efficient delivery of Cu, Zn superoxide dismutase gene. Mol Vis 2007;13:746.
30. Jain D, Banerjee R. Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery. J Biomed Mater Res B Appl Biomater 2008;86:105.
31. Wu Y, Yang W, Wang C, Hu J, Fu S. Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate. Int J Pharm 2005;295:235.
32. Zheng Y, Wu Y, Yang W, Wang C, Fu S, Shen X. Preparation, characterization, and drug release in vitro of chitosan-glycyrrhetic acid nanoparticles. J Pharm Sci 2006;95:181.
33. Choi EK, Park SR, Lee JH, Chung HS, Ahn HE, Rhee YH, et al. Induction of apoptosis by carboplatin and hyperthermia alone or combined in WERI human retinoblastoma cells. Int J Hyperthermia 2003;19:431.
34. Di Felice V, Lauricella M, Giuliano M, Emanuele S, Vento R, Tesoriere G. The apoptotic effects of cisplatin and carboplatin in retinoblastoma Y79 cells. Int J Oncol 1998;13:225.
35. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, Anderson RG. Caveolin, a protein component of caveolae membrane coats. Cell 1992;68:673.
36. Schnitzer JE, Oh P, Pinney E, Allard J. Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J Cell Biol 1994;127:1217.
37. Sofer A, Futerman AH. Cationic amphiphilic drugs inhibit the internalization of cholera toxin to the Golgi apparatus and the subsequent elevation of cyclic AMP. J Biol Chem 1995;270:12117.
38. Wang LH, Rothberg KG, Anderson RG. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol 1993;123:1107.
39. de Campos AM, Diebold Y, Carvalho EL, Sánchez A, Alonso MJ. Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharm Res 2004;21:803.
40. Dodane V, Khan MA, Merwin JR. Effect of chitosan on epithelial permeability and structure. Int J Pharm 1999;182:21.
41. Schipper NG, Olsson S, Hoogstraate JA, deBoer AG, Varum KM, Artursson P. Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement. Pharm Res 1997;14:923.
42. De S, Robinson D. Polymer relationships during preparation of chitosan-alginate and poly-l-lysine-alginate nanospheres. J Control Release 2003;89:101.
43. Li T, Shi XW, Du YM, Tang YF. Quaternized chitosan/alginate nanoparticles for protein delivery. J Biomed Mater Res A 2007;83:383.
44. Cafaggi S, Russo E, Stefani R, Leardi R, Caviglioli G, Parodi B, et al. Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex. J Control Release 2007;121:110.
45. Hay R, Miller S. Reactions of platinum (II) anticancer drugs. Kinetics of acid hydrolysis of cis-diammine (cyclobutane-1, 1-dicarboxylato)-platinum (II) "carboplatin". Polyhydron 1998;17:2337.
46. Myles ME, Neumann DM, Hill JM. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis. Adv Drug Deliv Rev 2005;57:2063.
47. Janes KA, Fresneau MP, Marazuela A, Fabra A, Alonso MJ. Chitosan nanoparticles as delivery systems for doxorubicin. J Control Release 2001;73:255.
48. Hamelers IH, van Loenen E, Staffhorst RW, de Kruijff B, de Kroon AI. Carboplatin nanocapsules: a highly cytotoxic, phospholipid-based formulation of carboplatin. Mol Cancer Ther 2006;5:2007.
49. Mu L, Feng SS. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol). J Control Release 2002;80:129.
50. Chavanpatil MD, Patil Y, Panyam J. Susceptibility of nanoparticle- encapsulated paclitaxel to P-glycoprotein-mediated drug efflux. Int J Pharm 2006;320:150.
51. Jabr-Milane LS, van Vlerken LE, Yadav S, Amiji MM. Multi-functional nanocarriers to overcome tumor drug resistance. Cancer Treat Rev 2008;34:592.
52. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003;55:329.
53. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005;4:145.
54. Huang M, Ma Z, Khor E, Lim LY. Uptake of FITC-chitosan nanoparticles by A549 cells. Pharm Res 2002;19:1488.
55. Douglas KL, Piccirillo CA, Tabrizian M. Cell line-dependent internalization pathways and intracellular trafficking determine transfection efficiency of nanoparticle vectors. Eur J Pharm Biopharm 2008;68:676.
56. Koping-Hoggard M, Varum KM, Issa M, Danielsen S, Christensen BE, Stokke BT, et al. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Ther 2004;11:1441.
57. Sabah JR, Davidson H, McConkey EN, Takemoto L. In vivo passage of albumin from the aqueous humor into the lens. Mol Vis 2004;10:254.